Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Book Value/Share Growth
11.45%
Quarterly · Period ending:
LCTX Book Value/Share Growth
Latest reported11.45%period ending
Latest reported11.45%period ending
LCTX Quarterly Book Value per Share Growth (QoQ) (0.00% → 11.45%)
Latest values, visible window
High-resolution chart · PNG
LCTX book value/share growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Book Value/Share Growth |
|---|---|
| 11.4464% | |
| 14.1694% | |
| 107.2903% | |
| -55.9542% | |
| -39.9432% | |
| -10.7008% | |
| 12.1133% | |
| -3.1231% | |
| -8.7422% | |
| 8.046% | |
| -5.768% | |
| -8.7401% | |
| 2.9686% | |
| -4.1255% | |
| -7.366% | |
| -5.2403% | |
| -4.0406% | |
| -7.3667% | |
| -23.9913% | |
| -7.8775% | |
| 5.4503% | |
| 15.7846% | |
| 5.481% | |
| -7.7799% | |
| -6.7528% | |
| -6.3012% | |
| -3.3125% | |
| -12.3706% | |
| -27.4146% | |
| 67.0604% | |
| -45.6442% | |
| 61.8613% | |
| 2.2378% | |
| -38.5773% | |
| -27.4707% | |
| 7.7543% | |
| -5.3646% | |
| 39.9902% | |
| -4.2676% | |
| 31.4998% | |
| 52.4491% | |
| -21.7382% | |
| 7.8315% | |
| -5.4057% | |
| 12.791% | |
| -8.6642% | |
| 40.2847% | |
| -24.2862% | |
| -2.7213% | |
| 3.6713% | |
| 64.6847% | |
| -28.9234% | |
| 9.5262% | |
| 18.8036% | |
| -16.7872% | |
| -12.6482% | |
| -7.1531% | |
| -11.3061% | |
| -14.1368% | |
| -4.1162% | |
| -8.4562% | |
| 4.0198% | |
| 15.2043% | |
| 8.2844% | |
| 172.7104% | |
| -6.4824% | |
| 149.2074% | |
| 533.6834% | |
| 84.344% | |
| -10.1219% | |
| 12.7058% | |
| -22.7191% | |
| -13.8373% | |
| -9.7539% | |
| -6.3242% | |
| -7.8541% | |
| -10.6143% | |
| -26.3712% | |
| -19.7994% | |
| -27.0465% | |
| -95.0875% | |
| -217.637% | |
| 85.9443% | |
| -50.4513% | |
| -130.0807% | |
| -193.2274% | |
| -60.9151% | |
| -34.0076% | |
| -28.1433% | |
| 169.8125% | |
| -11.6493% | |
| 17.2291% | |
| -23.9711% | |
| -50.9013% | |
| -196.9969% | |
| 78.2225% | |
| -107.8462% | |
| -653.5908% | |
| 90.7742% | |
| -528.0495% |